Identification of Breast Cancer-Restricted Antigens by Antibody Screening of SKBR3 cDNA Library Using a Preselected Patient's Serum

[1]  A. Ellis.  Breast , 2002, BMJ : British Medical Journal.

[2]  D. Jäger,et al.  Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Mazloum,et al.  Evidence that DNA polymerase delta isolated by immunoaffinity chromatography exhibits high-molecular weight characteristics and is associated with the KIAA0039 protein and RPA. , 2000, Biochemistry.

[4]  Yao-Tseng Chen.  Cancer vaccine: identification of human tumor antigens by SEREX. , 2000, Cancer journal.

[5]  T. Soussi,et al.  p53 Antibodies in the sera of patients with various types of cancer: a review. , 2000, Cancer research.

[6]  M. Pfreundschuh,et al.  Definition of tumor-associated antigens in hepatocellular carcinoma. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  M. Kasuga,et al.  A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. , 1999, Biochemical and biophysical research communications.

[8]  D. Jäger,et al.  Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. , 1999, Cancer research.

[9]  D. Jäger,et al.  Antigens recognized by autologous antibody in patients with renal‐cell carcinoma , 1999, International journal of cancer.

[10]  G. Salles,et al.  Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin’s lymphoma , 1999, Leukemia.

[11]  G Sybrecht,et al.  Role of amplified genes in the production of autoantibodies. , 1999, Blood.

[12]  P. Pujol,et al.  Increased immunostaining of fibulin-1, an estrogen-regulated protein in the stroma of human ovarian epithelial tumors. , 1998, The American journal of pathology.

[13]  Y. Yatabe,et al.  Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer. , 1998, Journal of the National Cancer Institute.

[14]  Yao-Tseng Chen,et al.  Characterization of human colon cancer antigens recognized by autologous antibodies , 1998, International journal of cancer.

[15]  H. Rochefort,et al.  Estradiol and fibulin‐1 inhibit motility of human ovarian‐ and breast‐cancer cells induced by fibronectin , 1998, International journal of cancer.

[16]  J. Wulfkuhle,et al.  Supervillin (p205): A Novel Membrane-associated, F-Actin–binding Protein in the Villin/Gelsolin Superfamily , 1997, The Journal of cell biology.

[17]  S. Ménard,et al.  High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  M. Pfreundschuh,et al.  Serological identification of human tumor antigens. , 1997, Current opinion in immunology.

[19]  J. Mccormick,et al.  Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines , 1997, Oncogene.

[20]  S. Ménard,et al.  Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  T. Sugimura,et al.  Molecular cloning of human GRB-7 co-amplified with CAB1 and c-ERBB-2 in primary gastric cancer. , 1997, Biochemical and biophysical research communications.

[22]  Yao-Tseng Chen,et al.  A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Y. Wang,et al.  Effect of decreased fte-1 gene expression on protein synthesis, cell growth, and transformation. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  H. Rochefort,et al.  Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Ménard,et al.  Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  M. Pfreundschuh,et al.  Human neoplasms elicit multiple specific immune responses in the autologous host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Byrd,et al.  Antibody to ras proteins in patients with colon cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  C. Haudenschild,et al.  The Interaction of Fibulin-1 with Fibrinogen , 1995, The Journal of Biological Chemistry.

[29]  J. B. Rattner,et al.  CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis , 1995, The Journal of cell biology.

[30]  D. Keene,et al.  The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  F. Mannello,et al.  Breast cancer diagnosis by lactate dehydrogenase isozymes in nipple discharge , 2006 .

[32]  S. Ménard,et al.  Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. , 1993, Cancer research.

[33]  L. Frati,et al.  Human B-cell immune response to the polymorphic epithelial mucin. , 1993, Cancer research.

[34]  S. Sukumar,et al.  Mutations in p53 as potential molecular markers for human breast cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Salmon,et al.  Circulating antibodies against c‐MYC oncogene product in sera of colorectal cancer patients , 1990, International journal of cancer.

[36]  P. Buamah,et al.  Lactate dehydrogenase isoenzyme 1 activity in sera of patients with ovarian cancer. , 1990, Clinical chemistry.

[37]  S. Hakomori,et al.  Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. , 1989, Advances in cancer research.

[38]  M. Willingham,et al.  Immunohistochemical localization of a thyroid hormone-binding protein (p55) in human tissues. , 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[39]  I. Pastan,et al.  Characterization of a membrane-associated 3,3',5-triiodo-L-thyronine binding protein by use of monoclonal antibodies. , 1986, Biochemistry.

[40]  A. Giuliano,et al.  LDH and melanoma , 1983, Cancer.

[41]  L. Old.  Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture. , 1981, Cancer research.